Commerzbank

DrKW builds exotic equity team

Dresdner Kleinwort Wasserstein has added four members to its exotic equity derivatives business. The hires were made to expand the team and the bank's structured products business.

MiFID Winners and Losers

A piece of compliance is presenting firms with such a technology hurdle that industry players are predicting a new host of opportunities.

Playing catch-up

The back office has found it difficult to keep up with front-office trading, prompting a warning by the FSA over the level of unsigned confirmations in the credit derivatives market earlier this year. Banks are now looking to improve the automation of…

JP Morgan bolsters derivatives marketing business

JP Morgan has hired four derivatives marketers for its streamlined derivatives marketing unit, including two managing directors from Deutsche Bank. They are the first significant appointments by the US investment bank since a steady stream of senior…

M&As spark op risk software shuffle

LONDON AND NEW YORK – Mergers and acquisitions are hotting up again in the op risk software industry. Two acquisition announcements in June have set tongues wagging on both sides of the Atlantic about who the next targets will be, and which potential…

Can research reinvent itself?

The provision of credit research to clients is undergoing sweeping reform, as regulatory concerns grow over potential conflicts of interest and banks reassess the value of giving out freebies. Philip Moore examines what this all adds up to for investors

Dresdner hires six FX directors

Dresdner Kleinwort Wasserstein (DrKW), the investment banking arm of Dresdner Bank, has appointed six key directors to its foreign exchange businesses in London and Frankfurt.

DrKW raids Calyon’s sales team

Dresdner Kleinwort Wasserstein, the investment banking arm of Frankfurt-based Dresdner Bank, has poached three senior members of Calyon’s structured investment products team to establish a structured products and derivatives sales team servicing US…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here